Clearpoint Neuro Inc
NASDAQ:CLPT

Watchlist Manager
Clearpoint Neuro Inc Logo
Clearpoint Neuro Inc
NASDAQ:CLPT
Watchlist
Price: 12.07 USD 0.92%
Market Cap: 332.9m USD
Have any thoughts about
Clearpoint Neuro Inc?
Write Note

Net Margin
Clearpoint Neuro Inc

-59.6%
Current
-83%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-59.6%
=
Net Income
-18.1m
/
Revenue
30.4m

Net Margin Across Competitors

Country US
Market Cap 331.1m USD
Net Margin
-60%
Country US
Market Cap 206.5B USD
Net Margin
14%
Country US
Market Cap 192.8B USD
Net Margin
29%
Country US
Market Cap 148.5B USD
Net Margin
16%
Country US
Market Cap 133.8B USD
Net Margin
11%
Country IE
Market Cap 111B USD
Net Margin
13%
Country US
Market Cap 65B USD
Net Margin
9%
Country DE
Market Cap 56.7B EUR
Net Margin
8%
Country CN
Market Cap 326.2B CNY
Net Margin
33%
Country US
Market Cap 42.5B USD
Net Margin
74%
Country US
Market Cap 38.1B USD
Net Margin
9%
No Stocks Found

Clearpoint Neuro Inc
Glance View

Market Cap
333m USD
Industry
Health Care

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 80 full-time employees. The company went IPO on 2019-07-03. The Company’s product platforms include SmartFlow Cannula and ClearPoint Navigation System Software. The SmartFlow Cannula is being utilized in approved combination product clinical and preclinical studies by pharmaceutical companies and academic research customers for various research and clinical trials in connection with delivery of therapeutic agents. The ClearPoint Navigation System Software is a software for surgical planning, navigation to target, and device delivery. The Company’s software and MRI-compatible workstation coordinate with the scanner to effectively utilize intraprocedural MR images. This provides real-time navigational instruction for the neurosurgeon to reach the desired anatomical target with a high degree of precision.

CLPT Intrinsic Value
6.91 USD
Overvaluation 43%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-59.6%
=
Net Income
-18.1m
/
Revenue
30.4m
What is the Net Margin of Clearpoint Neuro Inc?

Based on Clearpoint Neuro Inc's most recent financial statements, the company has Net Margin of -59.6%.